| Evaluating the Pharmacokinetics and Patient Outcomes of Buprenorphine Microdosing (NCT05307458) | United Health Services Hospitals, Inc. | 2022-07-01 |
| Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder (NCT05053503) | Spark Biomedical, Inc. | 2022-05-27 |
| Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD (NCT04759703) | Massachusetts General Hospital | 2022-01-24 |
| Assessing a Clinically-meaningful Opioid Withdrawal Phenotype (NCT05027919) | University of Maryland, Baltimore | 2021-12-01 |
| Surviving Opioid Overdose With Naloxone Education and Resuscitation Trial (SOONER) (NCT04740099) | Unity Health Toronto | 2021-12-01 |
| Novel Earpiece for Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal (NCT04731935) | Spark Biomedical, Inc. | 2021-03-18 |
| Combining Pregabalin (LYRICA®) With Lofexidine (LUCEMYRATM) to Treat OPIOID Withdrawal (NCT04218240) | University of Pennsylvania | 2020-12-17 |
| An Innovative Intervention for OUD Treatment (NCT04325659) | Johns Hopkins University | 2020-11-15 |
| Oral Cannabidiol for Opioid Withdrawal (NCT04238754) | Johns Hopkins University | 2020-11-01 |
| Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal (NCT04470050) | BioXcel Therapeutics Inc | 2020-06-09 |
| Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal (NCT04075214) | Spark Biomedical, Inc. | 2019-11-19 |
| Comparison of Three Opioid Detoxification Treatment Regimens (NCT03678792) | University of Alabama at Birmingham | 2019-11-15 |
| BRIDGE Device for Treatment of Opioid Withdrawal (NCT04162145) | BrightView LLC | 2019-11-15 |
| Opioid Tapering After Spine Surgery (NCT04140955) | Aarhus University Hospital | 2019-10-22 |
| Assessing Opioid Care Practices Using CPV Patient Simulation Modules (NCT04080037) | Qure Healthcare, LLC | 2019-09-03 |
| Lofexidine for Adults Undergoing Lumbar Spine Surgery (NCT04126083) | Mayo Clinic | 2019-09-01 |
| Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions (NCT04049799) | University of Vermont | 2019-08-08 |
| Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal (NCT03489161) | Virginia Commonwealth University | 2018-08-01 |
| Tapering From Long-term Opioid Therapy in Chronic Pain Population. Randomized Controlled Trial With 12 Months Follow up (NCT03485430) | Lund University Hospital | 2018-03-22 |
| Oxytocin Treatment of Opioid Dependence (NCT02548728) | University of North Carolina, Chapel Hill | 2016-02-01 |
| Open-Label, Safety Study of Lofexidine (NCT02363998) | USWM, LLC (dba US WorldMeds) | 2015-02-01 |
| Pregabalin for Opiate Withdrawal Syndrome (NCT03017430) | St. Petersburg Bekhterev Research Psychoneurological Institute | 2014-01-01 |
| Buprenorphine in the Emergency Department (NCT03174067) | St. Joseph's Health Centre Toronto | 2013-03-01 |
| 5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical Dependence (NCT01549652) | Stanford University | 2011-04-01 |
| Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent Individuals (NCT01262092) | University of Arkansas | 2010-10-01 |